Related by context. Frequent words. (Click for all words.) 73 Initiates Phase II 72 Presents Positive 72 Completes Enrollment 72 Announces FDA Clearance 71 Receives Orphan Drug Designation 71 Files Shelf Registration Statement 70 Pivotal Study 69 FDA Clears 69 Commences Phase 69 Inc Therapeutic Competitors 68 Q2 Loss Narrows 67 Q1 Loss Narrows 67 Corp BSX 67 Significantly Reduces 67 Completes Tender Offer 67 Receives FDA Clearance 67 Q2 Loss Widens 66 Q3 Loss Narrows 66 Patient Enrollment 66 Q4 Loss Narrows 66 Announces Initiation 66 FDA Accepts 66 Provides Guidance 66 Updates Guidance 66 Q3 Loss Widens 66 Pivotal Trial 65 Announces Presentation 65 Phase III Trial 65 Q4 Loss Widens 65 Improves Survival 65 Phase III Clinical Trial 65 Clinical Trial Results 65 Pivotal Phase III 65 Develop Novel 65 Initiate Phase 65 Q2 Profit Surges 65 Explore Strategic Alternatives 65 Issues Guidance 65 Significantly Increases 65 Cholesterol Drug 64 Receives CE 64 Announces Organizational Changes 64 Secures Financing 64 Single Dose 64 Posts Wider Loss 63 Announces Publication 63 Achieves Milestone 63 Receives Patent 63 Drug Candidate 63 Stockholders Approve Merger 63 Significantly Improves 63 Cyclacel Pharmaceuticals 63 Upcoming Conferences 63 CEO Exercises Options 63 Reports Positive 63 Initiates Phase 63 Metabasis Therapeutics 63 PROFILE CO 62 Webcast Annual Meeting 62 Reduces Risk 62 Regains Compliance With 62 Pulmonary Arterial Hypertension 62 Signs Licensing Agreement 62 Corp. Nasdaq GENZ 62 Preclinical Data 62 Pivotal Phase 62 Announces Successful Completion 62 submitted Biologics License 62 Hold Third Quarter 62 Bearish Pressure Building 62 Subsidiaries Consolidated Statement 62 Guides FY# Quick Facts 62 please visit http:/www.supergen.com 62 Extends Tender Offer 62 Receives Positive 62 Report companiesandmarkets.com adds 61 Holds Annual Meeting 61 Files Annual Report 61 Reconfirms 61 Finalizes Acquisition 61 Signs Agreements 61 Develop Next Generation 61 Provides Comprehensive 61 Transcept Pharmaceuticals 61 Declares Quarterly Dividends 61 Announces Definitive Agreement 61 FDA Approves 61 Bayhill Therapeutics 61 Study Demonstrates 61 Patent Issued 61 Drug Eluting Stent 60 FDA Clearance 60 Regains Compliance 60 Nasdaq ADLR 60 Receives Regulatory 60 Generic Version 60 DYAX 60 Calls Purchased 60 Provide Comprehensive 60 Small Molecule 60 AVEO Pharmaceuticals